{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:08:42Z","timestamp":1789553322635,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.humpath.2022.06.019","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:06:19Z","timestamp":1655949979000},"page":"114-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The many faces and pathologic diagnostic challenges of autoimmune hepatitis"],"prefix":"10.1016","volume":"132","author":[{"given":"Xuchen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanpat","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.06.019_bib1","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis","volume":"15","author":"Wang","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.humpath.2022.06.019_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.humpath.2018.07.014","article-title":"Histologic features of autoimmune hepatitis: a critical appraisal","volume":"82","author":"Gurung","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.019_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00795-014-0082-z","article-title":"The utility of IgG, IgM, and CD138 immunohistochemistry in the evaluation of autoimmune liver diseases","volume":"47","author":"Abe","year":"2014","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.humpath.2022.06.019_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/his.12558","article-title":"Assessment of the histopathological key features in autoimmune hepatitis","volume":"66","author":"de Boer","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.06.019_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","article-title":"Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis","volume":"48","author":"Miao","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.humpath.2022.06.019_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00428-021-03122-5","article-title":"A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center","volume":"479","author":"Franceschini","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.06.019_bib12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/liv.13083","article-title":"Bile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitis","volume":"36","author":"Verdonk","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2022.06.019_bib13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jcmm.14752","article-title":"Emperipolesis mediated by CD8(+) T cells correlates with biliary epithelia cell injury in primary biliary cholangitis","volume":"24","author":"Zhao","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humpath.2022.06.019_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","article-title":"Autoimmune hepatitis in Japan: trends in a nationwide survey","volume":"52","author":"Takahashi","year":"2017","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib15","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2022.06.019_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dld.2009.04.009","article-title":"Autoimmune hepatitis with acute presentation in Japan","volume":"42","author":"Miyake","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.humpath.2022.06.019_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.06.019_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis","volume":"28","author":"Misdraji","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.019_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/gut.41.2.269","article-title":"Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis","volume":"41","author":"Te","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.06.019_bib20","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1572-0241.2002.06052.x","article-title":"Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature","volume":"97","author":"Singh","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib21","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.humpath.2007.03.019","article-title":"Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis?","volume":"38","author":"Zen","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.019_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","article-title":"Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients","volume":"70","author":"Nguyen Canh","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.06.019_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/hep.1840150403","article-title":"The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis","volume":"15","author":"Bach","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib24","article-title":"Postinfantile giant cell hepatitis: an etiological and prognostic perspective","volume":"2013","author":"Bihari","year":"2013","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.humpath.2022.06.019_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4254\/wjh.v11.i12.752","article-title":"Post-infantile giant cell hepatitis: a single center's experience over 25 years","volume":"11","author":"Matta","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1432-2277.1998.tb00980.x","article-title":"Recurrent postinfantile syncytial giant cell hepatitis after orthotopic liver transplantation","volume":"11","author":"Lerut","year":"1998","journal-title":"Transpl Int"},{"key":"10.1016\/j.humpath.2022.06.019_bib27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/PAS.0000000000000395","article-title":"Hyaline droplets in Kupffer cells: a novel diagnostic clue for autoimmune hepatitis","volume":"39","author":"Tucker","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.019_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jceh.2021.04.013","article-title":"Kupffer cell hyaline globules in children with autoimmune hepatitis","volume":"12","author":"Khedr","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.dld.2017.04.001","article-title":"Glassy droplet inclusions within the cytoplasm of Kupffer cells: a novel ultrastructural feature for the diagnosis of pediatric autoimmune hepatitis","volume":"49","author":"Lotowska","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.humpath.2022.06.019_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2022.06.019_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria","volume":"30","author":"Balitzer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.019_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/hepr.13678","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2020","volume":"51","author":"Yoshiji","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.humpath.2022.06.019_bib34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ajg.2015.139","article-title":"Long-term prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis","volume":"110","author":"Dhaliwal","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.humpath.2022.06.019_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib38","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s10620-010-1243-0","article-title":"Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawal","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2022.06.019_bib39","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2022.06.019_bib40","first-page":"665","article-title":"A method to assess the distribution and frequency of plasma cells and plasma cell precursors in autoimmune hepatitis","volume":"33","author":"Rubio","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2022.06.019_bib41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2022.06.019_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2008.08.043","article-title":"Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis","volume":"7","author":"Mehendiratta","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00508-021-01907-x","article-title":"Seronegative autoimmune hepatitis in children : a real diagnostic challenge","volume":"134","author":"Khedr","year":"2022","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.humpath.2022.06.019_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib46","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib47","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3892\/etm.2015.2694","article-title":"Anti-mitochondrial M2 antibody-positive autoimmune hepatitis","volume":"10","author":"Tomizawa","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.humpath.2022.06.019_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.humpath.2022.06.019_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12016-013-8383-x","article-title":"Autoimmune features in metabolic liver disease: a single-center experience and review of the literature","volume":"45","author":"Tsuneyama","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.humpath.2022.06.019_bib50","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00535-005-1711-z","article-title":"Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?","volume":"40","author":"Yatsuji","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib51","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib52","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.3748\/wjg.v27.i43.7563","article-title":"Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: a prospective multi-centre cohort study","volume":"27","author":"De Roza","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib53","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2014.01.010","article-title":"Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"McPherson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2022.06.019_bib54","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/1751-2980.12646","article-title":"Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease","volume":"19","author":"Sun","year":"2018","journal-title":"J Digest Dis"},{"key":"10.1016\/j.humpath.2022.06.019_bib55","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2022.06.019_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jgh3.12046","article-title":"Non-alcoholic fatty liver disease in patients with autoimmune hepatitis","volume":"2","author":"Takahashi","year":"2018","journal-title":"JGH Open"},{"key":"10.1016\/j.humpath.2022.06.019_bib57","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.31599","article-title":"NAFLD: reporting histologic findings in clinical practice","volume":"73","author":"Brunt","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib58","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib59","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1111\/liv.15044","article-title":"Autoimmune hepatitis triggered by COVID-19: a report of two cases","volume":"41","author":"Kabacam","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2022.06.019_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5578\/mb.67262","article-title":"Investigation of antinuclear antibodies in chronic hepatitis B patients","volume":"52","author":"Sener","year":"2018","journal-title":"Mikrobiyoloji Bulteni"},{"key":"10.1016\/j.humpath.2022.06.019_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2018-000203","article-title":"Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations","volume":"5","author":"Gilman","year":"2018","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib62","first-page":"12","article-title":"Correlation of autoimmune reactivity with hepatitis B and C virus (HBV and HCV) infection in histologically proven chronic liver diseases","volume":"20","author":"Shantha","year":"2002","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.humpath.2022.06.019_bib63","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3109\/00365521.2013.772231","article-title":"Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B\/C","volume":"48","author":"Efe","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2893.2004.00530.x","article-title":"Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance","volume":"11","author":"Yee","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.humpath.2022.06.019_bib65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaut.2019.04.019","article-title":"Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents","volume":"102","author":"Terziroli Beretta-Piccoli","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.humpath.2022.06.019_bib66","doi-asserted-by":"crossref","first-page":"11631","DOI":"10.18632\/oncotarget.24391","article-title":"Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis","volume":"9","author":"Kanda","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2022.06.019_bib67","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib68","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jmii.2019.04.009","article-title":"Occult HBV infection in patients with autoimmune hepatitis: a virological and clinical study","volume":"53","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.humpath.2022.06.019_bib69","doi-asserted-by":"crossref","first-page":"870","DOI":"10.5009\/gnl16434","article-title":"Reactivation of hepatitis C virus and its clinical outcomes in patients treated with systemic chemotherapy or immunosuppressive therapy","volume":"11","author":"Lee","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.humpath.2022.06.019_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15403\/jgld.2014.1121.251.hpe","article-title":"Seroprevalence of hepatitis E virus in autoimmune hepatitis patients in The Netherlands","volume":"25","author":"van Gerven","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.humpath.2022.06.019_bib71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.18-0640","article-title":"Case report: acute hepatitis E in a pediatric traveler presenting with features of autoimmune hepatitis: a diagnostic and therapeutic challenge","volume":"100","author":"Minkoff","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.humpath.2022.06.019_bib72","article-title":"Acute hepatitis E presenting with clinical feature of autoimmune hepatitis","volume":"6","author":"Patel","year":"2016","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.humpath.2022.06.019_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.32074\/1591-951X-241","article-title":"Pathology of autoimmune hepatitis","volume":"113","author":"Covelli","year":"2021","journal-title":"Pathologica"},{"key":"10.1016\/j.humpath.2022.06.019_bib74","first-page":"68","article-title":"Subacute liver failure due to autochthonous hepatitis E virus infection in an elderly man in the United States","volume":"12","author":"Landry","year":"2018","journal-title":"Hum Pathol: Case Report"},{"key":"10.1016\/j.humpath.2022.06.019_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085330","article-title":"Increased HEV seroprevalence in patients with autoimmune hepatitis","volume":"9","author":"Pischke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2022.06.019_bib76","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cld.2013.07.004","article-title":"Histopathologic manifestations of drug-induced hepatotoxicity","volume":"17","author":"Zhang","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.humpath.2022.06.019_bib77","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5858\/arpa.2020-0070-RA","article-title":"Pathologic manifestations of gastrointestinal and hepatobiliary injury in immune checkpoint inhibitor therapy","volume":"145","author":"Patil","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2022.06.019_bib78","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib79","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2022.06.019_bib80","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/00004836-200411000-00015","article-title":"Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis","volume":"38","author":"Hong-Curtis","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.019_bib81","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.12998\/wjcc.v8.i18.4075","article-title":"Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: a case report and systematic review","volume":"8","author":"Ballotin","year":"2020","journal-title":"World J Clin Cases"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:43:00Z","timestamp":1758645780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722001642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":81,"alternative-id":["S0046817722001642"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.019","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The many faces and pathologic diagnostic challenges of autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}